Stocks making the biggest moves premarket: MRNA, LOW, EL

Pharmaceutical companies Moderna and Merck experienced significant stock increases following positive results from a late-stage trial of a personalized cancer vaccine developed collaboratively. Moderna’s shares surged by as much as 57%, while Merck’s shares rose just over 6%. The timeline for submitting applications for regulatory approval of the vaccine in the United States has not been disclosed.

In the semiconductor sector, Marvell Technology’s stock climbed more than 11% after announcing Google’s intention to acquire a $12 billion stake in the company, aimed at developing custom chips for Google’s parent company, Alphabet. Keysight Technologies also saw a 2% rise in its shares after reporting third-quarter results that exceeded analyst expectations, posting earnings of $3.07 per share and revenues of $1.85 billion.

Conversely, Lowe’s shares dipped by 2% following an update to its full-year sales and earnings outlook, highlighting pressures in home improvement spending. Target’s stock fell by 1.5% despite posting better-than-expected quarterly revenues and raising its full-year guidance, attributing gains to tariff refunds.

La-Z-Boy faced a sharp decline of nearly 17% after posting first-quarter earnings below expectations and issuing a revenue forecast that also fell short of analyst estimates. Mercury Systems saw a stock decrease of over 9% after its fiscal year revenue outlook was slightly above consensus, yet its adjusted earnings missed expectations. On the contrary, Toll Brothers reported a modest increase of just over 1% after third-quarter earnings exceeded forecasts. Similarly, Estee Lauder’s stock gained more than 7% following strong earnings and revenue reports. Analog Devices rose over 3% with strong fiscal third-quarter results and positive guidance.

Why this story matters

  • Significant movements in the stock market can affect investor sentiment and industry trends.

Key takeaway

  • Positive earnings reports and strategic partnerships can boost stock prices, while missed targets can lead to declines.

Opposing viewpoint

  • Not all stocks react uniformly to earnings reports; external market conditions and sales pressures can influence share performance negatively.

Source link

More From Author

American Airlines to outfit narrow-body jets with more premium seats — betting on high-spending travelers

Overlooked Decisions That Help Small Businesses Grow

Leave a Reply

Your email address will not be published. Required fields are marked *